Enanta Pharmaceuticals (ENTA) Prepaid Assets (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Prepaid Assets of $6.8 million for Q1 2026, down 23.11% year-on-year from $8.9 million in Q1 2025, and up 56.84% on a QoQ basis from $4.3 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Prepaid Assets data on file, last reported at $6.8 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 23.11% year-over-year to $6.8 million; the trailing twelve-month figure through Mar 2026 stood at $6.8 million (down 23.11% YoY), and the FY2025 full-year result was $8.6 million, down 30.8% from the prior year.
- Prepaid Assets for Q1 2026 stood at $6.8 million, up from $4.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $17.9 million in Q4 2022 and bottomed at $4.3 million in Q4 2025.
- The 5-year median for Prepaid Assets is $12.4 million (2024), against an average of $12.0 million.
- The widest annual swing landed in 2022, when Prepaid Assets soared 55.97%; it then slumped 59.36% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $17.9 million in 2022, then declined by 26.2% to $13.2 million in 2023, then declined by 19.34% to $10.7 million in 2024, then sank by 59.36% to $4.3 million in 2025, then jumped by 56.84% to $6.8 million in 2026.
- The last three Prepaid Assets figures came in at $6.8 million (Q1 2026), $4.3 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | 4.34 Mn |
| Sep 30, 2025 | 8.59 Mn |
| Jun 30, 2025 | 10.24 Mn |
| Mar 31, 2025 | 8.86 Mn |
| Dec 31, 2024 | 10.68 Mn |
| Sep 30, 2024 | 12.41 Mn |
| Jun 30, 2024 | 15.26 Mn |
| Mar 31, 2024 | 10.93 Mn |
| Dec 31, 2023 | 13.25 Mn |
| Sep 30, 2023 | 13.26 Mn |
| Jun 30, 2023 | 17.07 Mn |
| Mar 31, 2023 | 14.48 Mn |
| Dec 31, 2022 | 17.95 Mn |
| Sep 30, 2022 | 13.45 Mn |
| Jun 30, 2022 | 11.54 Mn |
| Mar 31, 2022 | 14.08 Mn |
| Dec 31, 2021 | 11.51 Mn |
| Sep 30, 2021 | 14.19 Mn |
| Jun 30, 2021 | 12.14 Mn |
| Mar 31, 2021 | 32.14 Mn |
| Dec 31, 2020 | 28.00 Mn |
| Sep 30, 2020 | 13.66 Mn |
| Jun 30, 2020 | 24.73 Mn |
| Mar 31, 2020 | 19.84 Mn |
| Dec 31, 2019 | 14.15 Mn |
| Sep 30, 2019 | 15.30 Mn |
| Jun 30, 2019 | 17.65 Mn |
| Mar 31, 2019 | 14.05 Mn |
| Dec 31, 2018 | 7.64 Mn |
| Sep 30, 2018 | 4.45 Mn |
| Jun 30, 2018 | 9.40 Mn |
| Mar 31, 2018 | 4.91 Mn |
| Dec 31, 2017 | 4.08 Mn |
| Sep 30, 2017 | 3.54 Mn |
| Jun 30, 2017 | 6.59 Mn |
| Mar 31, 2017 | 6.06 Mn |
| Dec 31, 2016 | 4.29 Mn |
| Sep 30, 2016 | 9.23 Mn |
| Jun 30, 2016 | 8.20 Mn |
| Mar 31, 2016 | 7.66 Mn |
| Dec 31, 2015 | 8.54 Mn |
| Sep 30, 2015 | 8.27 Mn |
| Jun 30, 2015 | 3.50 Mn |
| Mar 31, 2015 | 2.23 Mn |
| Dec 31, 2014 | 1.22 Mn |
| Sep 30, 2014 | 1.59 Mn |
| Jun 30, 2014 | 1.95 Mn |
| Mar 31, 2014 | 1.98 Mn |
| Dec 31, 2013 | 1.28 Mn |
| Sep 30, 2013 | 1.64 Mn |
| Jun 30, 2013 | 1.46 Mn |
| Mar 31, 2013 | 1.12 Mn |
| Sep 30, 2012 | 604,000.00 |